Literature DB >> 21372840

IGHV unmutated CLL B cells are more prone to spontaneous apoptosis and subject to environmental prosurvival signals than mutated CLL B cells.

M Coscia1, F Pantaleoni, C Riganti, C Vitale, M Rigoni, S Peola, B Castella, M Foglietta, V Griggio, D Drandi, M Ladetto, A Bosia, M Boccadoro, M Massaia.   

Abstract

Tumor cells in chronic lymphocytic leukemia (CLL) are more prone to apoptosis when cultured ex vivo, because they lack prosurvival signals furnished in vivo via B-cell receptor (BCR)-dependent and -independent pathways. This study compared the susceptibility of unmutated (UM) and mutated (M) CLL B cells to spontaneous apoptosis and prosurvival signals. UM CLL B cells showed a significantly higher rate of spontaneous apoptosis than M CLL B cells. Nuclear factor-kB (NF-kB) was rapidly inactivated, and B-cell leukemia/lymphoma 2 (Bcl-2) expression progressively down-regulated in the UM CLL B cells. CD40-Ligand, interleukin-4 and stromal cells significantly improved their viability and partially recovered Bcl-2, but not NF-kB expression. Peripheral blood mononuclear cells also offered protection of UM CLL B cells, and recovered both NF-kB and Bcl-2 expression. T cells, rather than nurse-like cells, were responsible for protecting UM CLL B cells by means of cell-to-cell contact and soluble factors. Despite their more aggressive features, UM CLL B cells are more susceptible to spontaneous apoptosis and depend from environmental prosurvival signals. This vulnerability of UM CLL B cells can be exploited as a selective target of therapeutic interventions.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21372840     DOI: 10.1038/leu.2011.12

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  28 in total

Review 1.  Targeting the B cell receptor pathway in chronic lymphocytic leukemia.

Authors:  Matthew S Davids; Jennifer R Brown
Journal:  Leuk Lymphoma       Date:  2012-12

2.  The cytotoxic activity of Aplidin in chronic lymphocytic leukemia (CLL) is mediated by a direct effect on leukemic cells and an indirect effect on monocyte-derived cells.

Authors:  Pablo E Morande; Samanta R Zanetti; Mercedes Borge; Paula Nannini; Carolina Jancic; Raimundo F Bezares; Alicia Bitsmans; Miguel González; Andrea L Rodríguez; Carlos M Galmarini; Romina Gamberale; Mirta Giordano
Journal:  Invest New Drugs       Date:  2011-09-02       Impact factor: 3.850

3.  TCL1A and ATM are co-expressed in chronic lymphocytic leukemia cells without deletion of 11q.

Authors:  Angela Garding; Nupur Bhattacharya; Sarah Haebe; Frederike Müller; Dieter Weichenhan; Irina Idler; Katja Ickstadt; Stephan Stilgenbauer; Daniel Mertens
Journal:  Haematologica       Date:  2012-08-08       Impact factor: 9.941

Review 4.  NF-κB signaling pathway and its potential as a target for therapy in lymphoid neoplasms.

Authors:  Li Yu; Ling Li; L Jeffrey Medeiros; Ken H Young
Journal:  Blood Rev       Date:  2016-10-13       Impact factor: 8.250

5.  T-cell independent, B-cell receptor-mediated induction of telomerase activity differs among IGHV mutation-based subgroups of chronic lymphocytic leukemia patients.

Authors:  Rajendra N Damle; Sonal Temburni; Taraneh Banapour; Santanu Paul; Patricia K A Mongini; Steven L Allen; Jonathan E Kolitz; Kanti R Rai; Nicholas Chiorazzi
Journal:  Blood       Date:  2012-08-08       Impact factor: 22.113

6.  Pro-apoptotic TP53 homolog TAp63 is repressed via epigenetic silencing and B-cell receptor signalling in chronic lymphocytic leukaemia.

Authors:  Leigh A Humphries; J Claire Godbersen; Olga V Danilova; Prabhjot Kaur; Brock C Christensen; Alexey V Danilov
Journal:  Br J Haematol       Date:  2013-09-30       Impact factor: 6.998

7.  Physical contact with endothelial cells through β1- and β2- integrins rescues chronic lymphocytic leukemia cells from spontaneous and drug-induced apoptosis and induces a peculiar gene expression profile in leukemic cells.

Authors:  Rossana Maffei; Stefania Fiorcari; Jenny Bulgarelli; Silvia Martinelli; Ilaria Castelli; Silvia Deaglio; Giulia Debbia; Marcella Fontana; Valeria Coluccio; Goretta Bonacorsi; Patrizia Zucchini; Franco Narni; Giuseppe Torelli; Mario Luppi; Roberto Marasca
Journal:  Haematologica       Date:  2011-12-29       Impact factor: 9.941

8.  RelB, together with RelA, sustains cell survival and confers proteasome inhibitor sensitivity of chronic lymphocytic leukemia cells from bone marrow.

Authors:  Jingjing Xu; Peng Zhou; Wenjuan Wang; Aining Sun; Feng Guo
Journal:  J Mol Med (Berl)       Date:  2013-09-17       Impact factor: 4.599

9.  Colony-Stimulating Factor-1 Receptor Is Required for Nurse-like Cell Survival in Chronic Lymphocytic Leukemia.

Authors:  Avery Polk; Ye Lu; Tianjiao Wang; Erlene Seymour; Nathanael G Bailey; Jack W Singer; Philip S Boonstra; Megan S Lim; Sami Malek; Ryan A Wilcox
Journal:  Clin Cancer Res       Date:  2016-06-22       Impact factor: 12.531

10.  Basal Ca(2+) signaling is particularly increased in mutated chronic lymphocytic leukemia.

Authors:  A F Muggen; S Y Pillai; L P Kil; M C van Zelm; J J M van Dongen; R W Hendriks; A W Langerak
Journal:  Leukemia       Date:  2014-06-11       Impact factor: 11.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.